Blog
RSS FeedPosted by Michael Wonder on 19 Apr 2024
Publication of Stage 1 and Stage 2 PBS Process Improvements metrics report for 2022-23
19 April 2024 - The 2022-23 Stage 1 and Stage 2 PBS process improvements metrics report is now available on ...
Posted by Michael Wonder on 15 Apr 2024
Updates to the HTA Policy and Methods Review Reference Committee (15 April 2024)
15 April 2024 - The HTA Review Reference Committee is finalising its report and recommendations to the Australian Government having ...
Posted by Michael Wonder on 12 Apr 2024
Waiting for new medicines in Canada, Europe, and the United States: study finds Americans get better and faster access to innovative drugs
11 April 2024 - A recent study published by the Canadian Health Policy Institute examined the availability and wait times ...
Posted by Michael Wonder on 10 Apr 2024
New target zero initiative aims to help improve access to new drugs
9 April 2024 - Target Zero is a new initiative that aims to improve the time to access for patients ...
Posted by Michael Wonder on 28 Feb 2024
Minister announces parallel assessment means new medicines assessed sooner
28 February 2024 - PHARMAC is changing its process so it can assess a funding application at the same time Medsafe ...
Posted by Michael Wonder on 09 Dec 2023
Medicines lobby says the PBS has not kept up with advances — or approvals — in medicines
8 December 2023 - Little Jack Roche was five weeks old when diagnosed with cystic fibrosis. The medication that could help ...
Posted by Michael Wonder on 02 Dec 2023
Updates to the HTA Policy and Methods Review Reference Committee (1 December 2023)
1 December 2023 - To ensure that the Reference Committee has sufficient time to consider the extensive and valuable input ...
Posted by Michael Wonder on 01 Dec 2023
New frontier will lead to better health outcomes
30 November 2023 - The Government has today tabled its response to an inquiry considering how to give Australian patients timely ...
Posted by Michael Wonder on 20 Nov 2023
NICE gets ready to assess new dementia treatments
20 November 2023 - NICE’s methods and processes for evaluating new treatments for use in the NHS are appropriate for the ...
Posted by Michael Wonder on 26 Apr 2023
Time taken for PHARMAC funding decisions ‘too long’, says Medicines NZ
26 April 2023 - It takes the nation's drug-buying agency, PHARMAC, an average of 7.7 years to make funding decisions ...
Posted by Michael Wonder on 21 Apr 2023
Publication of stage 1 and stage 2 PBS process improvements metrics report (2021-22)
21 April 2023 - The 2021-22 Stage 1 and Stage 2 PBS process improvements metrics report is now available. ...
Posted by Michael Wonder on 16 Apr 2023
Price of a life: Australians wait two years longer for breakthrough medicines than US citizens
16 April 2023 - Australians are waiting two years longer to access new lifesaving subsidised medicines because of pharma giants. Now, ...
Posted by Michael Wonder on 13 Feb 2023
Like Medicare, the PBS urgently needs overhauling – for all our sakes
10 February 2023 - Trent Zimmerman says it would be a mistake for Australia to narrow its health reform agenda ...
Posted by Michael Wonder on 08 Feb 2023
Speeding up access to new medicines in Scotland: abbreviated process
8 February 2023 - A process brought in to streamline decision-making around access to new medicines in NHSScotland during the ...
Posted by Michael Wonder on 26 Jan 2023
Draft methods (version 7.0): IQWiG is extending the comment period
26 January 2023 - The new deadline is 28 February 2023. ...